Cargando…
Image-Based In Vitro Screening Reveals the Trypanostatic Activity of Hydroxymethylnitrofurazone against Trypanosoma cruzi
Hydroxymethylnitrofurazone (NFOH) is a therapeutic candidate for Chagas disease (CD). It has negligible hepatotoxicity in a murine model compared to the front-line drug benznidazole (BZN). Here, using Trypanosoma cruzi strains that express bioluminescent and/or fluorescent reporter proteins, we furt...
Autores principales: | Scarim, Cauê Benito, Olmo, Francisco, Ferreira, Elizabeth Igne, Chin, Chung Man, Kelly, John M., Fortes Francisco, Amanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268475/ https://www.ncbi.nlm.nih.gov/pubmed/34203228 http://dx.doi.org/10.3390/ijms22136930 |
Ejemplares similares
-
Resveratrol and Curcumin for Chagas Disease Treatment—A Systematic Review
por: Imperador, Carlos Henrique Lima, et al.
Publicado: (2022) -
Host and parasite genetics shape a link between Trypanosoma cruzi infection dynamics and chronic cardiomyopathy
por: Lewis, Michael D., et al.
Publicado: (2016) -
A New Experimental Model for Assessing Drug Efficacy against Trypanosoma cruzi Infection Based on Highly Sensitive In Vivo Imaging
por: Lewis, Michael D., et al.
Publicado: (2015) -
The Trypanosoma cruzi Vitamin C Dependent Peroxidase Confers Protection against Oxidative Stress but Is Not a Determinant of Virulence
por: Taylor, Martin C., et al.
Publicado: (2015) -
Optimising genetic transformation of Trypanosoma cruzi using hydroxyurea-induced cell-cycle synchronisation
por: Olmo, Francisco, et al.
Publicado: (2018)